We’re Driven by a Bold Mission: Engineering A Safer Workplace. Without Compromise.

About

Salus Scientific started with a simple question:

Why should the people who spend their careers caring for others have to sacrifice their own health to do it?

Salus Scientific is a medical technology company advancing a new standard of protection for the physicians, nurses and technologists who work in fluoroscopy-guided procedures. Its integrated portfolio addresses two of the most persistent hazards in interventional medicine: cumulative scatter radiation exposure and the physical burden of traditional lead protection. Salus was founded on the belief that occupational hazards should not be accepted as an unavoidable part of a career in medicine.Founded in Charleston, South Carolina, the company set out to engineer radiation protection that works with clinicians rather than against them. GLiFT came first (a patented endoskeleton that lifts the weight of lead off the body) followed by AeroShield, Salus Garments, and the Salus Lab service program. Together, they form the only full radiation protection solution for the lab, built on one promise: safety without compromise.

Our Mission

To create safer procedural environments by reducing occupational radiation exposure and the physical burden of traditional radiation protection. Engineering A Safer Workplace. Without Compromise.

Our Vision

To set a new global standard in radiation protection, where every healthcare professional is equipped to work safely, comfortably, and confidently throughout their career.

Leadership Team

Driving Innovation Through Leadership

We are a team united by shared values and a single vision: a safer lab for everyone in it. We advance our mission by delivering the only complete radiation reduction solution, protecting the clinicians and staff who take on the most demanding interventional procedures every day.

Todd O. Flohr

CEO & Chairman of the Board, Co-Founder

Todd Flohr is Co-Founder, CEO and Chairman of Salus Scientific, a medical technology company dedicated to protecting the physicians, nurses and technologists who work in the fluoroscopy suite. He founded the company on a simple premise: the clinicians who spend their careers delivering image-guided care deserve the same level of protection as the patients on the table.

Salus began with a practicing physician's solution to his own occupational injury. Flohr recognized its potential to address a problem affecting interventional teams nationwide and built a company around it, guiding GLiFT™ from concept through patent to a commercial product now in use at leading U.S. health systems. Under his leadership, Salus has grown from a single device into a portfolio spanning radiation protection, protective garments and occupational wellness services.

As CEO and Chairman, Flohr directs the company's strategy and operations. He has led Salus through its Series A financing, the commercial launch of AeroShield™, and the opening of two production facilities in South Carolina.

Flohr brings more than two decades of experience in medical device commercialization, having held senior roles at HeartFlow, Vital Connect, St. Jude Medical, AccessClosure and Abbott Vascular. He holds a B.A. in Corporate Communications from the College of Charleston.

Read More

Todd Flohr is Co-Founder, CEO and Chairman of Salus Scientific, a medical technology company dedicated to protecting the physicians, nurses and technologists who work in the fluoroscopy suite. He founded the company on a simple premise: the clinicians who spend their careers delivering image-guided care deserve the same level of protection as the patients on the table.

Salus began with a practicing physician's solution to his own occupational injury. Flohr recognized its potential to address a problem affecting interventional teams nationwide and built a company around it, guiding GLiFT™ from concept through patent to a commercial product now in use at leading U.S. health systems. Under his leadership, Salus has grown from a single device into a portfolio spanning radiation protection, protective garments and occupational wellness services.

As CEO and Chairman, Flohr directs the company's strategy and operations. He has led Salus through its Series A financing, the commercial launch of AeroShield™, and the opening of two production facilities in South Carolina.

Flohr brings more than two decades of experience in medical device commercialization, having held senior roles at HeartFlow, Vital Connect, St. Jude Medical, AccessClosure and Abbott Vascular. He holds a B.A. in Corporate Communications from the College of Charleston.

Read More

Todd Flohr is Co-Founder, CEO and Chairman of Salus Scientific, a medical technology company dedicated to protecting the physicians, nurses and technologists who work in the fluoroscopy suite. He founded the company on a simple premise: the clinicians who spend their careers delivering image-guided care deserve the same level of protection as the patients on the table.

Salus began with a practicing physician's solution to his own occupational injury. Flohr recognized its potential to address a problem affecting interventional teams nationwide and built a company around it, guiding GLiFT™ from concept through patent to a commercial product now in use at leading U.S. health systems. Under his leadership, Salus has grown from a single device into a portfolio spanning radiation protection, protective garments and occupational wellness services.

As CEO and Chairman, Flohr directs the company's strategy and operations. He has led Salus through its Series A financing, the commercial launch of AeroShield™, and the opening of two production facilities in South Carolina.

Flohr brings more than two decades of experience in medical device commercialization, having held senior roles at HeartFlow, Vital Connect, St. Jude Medical, AccessClosure and Abbott Vascular. He holds a B.A. in Corporate Communications from the College of Charleston.

Read More

Keith Rosmarin

President & CFO

Keith Rosmarin is President and Chief Financial Officer of Salus Scientific, a medical technology company dedicated to protecting the clinicians who work in the fluoroscopy suite. He sets the company's financial and strategic direction, drawing on two decades of experience in finance and investment management.

Rosmarin became the first non-founding investor in Salus in 2020, backing the company before it had a product on the market. He went on to design its corporate structure, capitalization and financing strategy, laying the foundation that brought that product to market. He has since led the company's primary financing rounds and drove the commercial launch of its core GLiFT™ platform.

Rosmarin is the founder of Harbor Hill Investments, the private equity fund through which he first invested in Salus. He remains active across its portfolio, serving on the board of LnQ Inc. and advising portfolio company leadership.

Earlier in his career, Rosmarin was Director of US Fundamental Trading at Surveyor Capital, a division of Citadel LLC. He previously spent more than 15 years as a Director in Citigroup's Equity Division and as a Partner at Level Global Investors, LP. He holds a dual degree in Economics and Government from Lafayette College.

Read More

Keith Rosmarin is President and Chief Financial Officer of Salus Scientific, a medical technology company dedicated to protecting the clinicians who work in the fluoroscopy suite. He sets the company's financial and strategic direction, drawing on two decades of experience in finance and investment management.

Rosmarin became the first non-founding investor in Salus in 2020, backing the company before it had a product on the market. He went on to design its corporate structure, capitalization and financing strategy, laying the foundation that brought that product to market. He has since led the company's primary financing rounds and drove the commercial launch of its core GLiFT™ platform.

Rosmarin is the founder of Harbor Hill Investments, the private equity fund through which he first invested in Salus. He remains active across its portfolio, serving on the board of LnQ Inc. and advising portfolio company leadership.

Earlier in his career, Rosmarin was Director of US Fundamental Trading at Surveyor Capital, a division of Citadel LLC. He previously spent more than 15 years as a Director in Citigroup's Equity Division and as a Partner at Level Global Investors, LP. He holds a dual degree in Economics and Government from Lafayette College.

Read More

Keith Rosmarin is President and Chief Financial Officer of Salus Scientific, a medical technology company dedicated to protecting the clinicians who work in the fluoroscopy suite. He sets the company's financial and strategic direction, drawing on two decades of experience in finance and investment management.

Rosmarin became the first non-founding investor in Salus in 2020, backing the company before it had a product on the market. He went on to design its corporate structure, capitalization and financing strategy, laying the foundation that brought that product to market. He has since led the company's primary financing rounds and drove the commercial launch of its core GLiFT™ platform.

Rosmarin is the founder of Harbor Hill Investments, the private equity fund through which he first invested in Salus. He remains active across its portfolio, serving on the board of LnQ Inc. and advising portfolio company leadership.

Earlier in his career, Rosmarin was Director of US Fundamental Trading at Surveyor Capital, a division of Citadel LLC. He previously spent more than 15 years as a Director in Citigroup's Equity Division and as a Partner at Level Global Investors, LP. He holds a dual degree in Economics and Government from Lafayette College.

Read More

Jon A. Wallace, R.Ph., J.D.

General Counsel & Board of Directors

Jon Wallace serves as General Counsel and as a member of the Board of Directors of Salus Scientific Corp., where he advises the company and its board on the legal, regulatory, and corporate issues that come with bringing radiation protection technology to market. His work spans FDA medical device regulation and product classification, quality system and labeling requirements, intellectual property strategy, hospital and distributor contracting, supply chain and vendor agreements, corporate governance, and financing and transactional matters.

Jon brings an operator's perspective to the role. He has served as chief executive officer of, and as a director of, pharmaceutical and related companies, and that experience shapes how he counsels Salus on commercialization, growth, and board-level strategy. A pharmacist as well as a lawyer, Jon has built his career in drug, medical device, and health law — including FDA matters, board licensing and permitting, controlled substances, and federal and state compliance governing the purchase and sale of pharmaceutical and medical device products. He began his legal career at Nelson Mullins Riley & Scarborough LLP.

Jon is an Adjunct Clinical Professor in the Department of Clinical Pharmacy and Outcome Sciences at the Medical University of South Carolina College of Pharmacy, and has served in the same role at the University of South Carolina College of Pharmacy. He earned his B.S. in Pharmacy from the University of North Carolina at Chapel Hill and his J.D., magna cum laude, from the University of South Carolina School of Law, where he was Associate Editor-in-Chief of the South Carolina Law Review.

Read More

Jon Wallace serves as General Counsel and as a member of the Board of Directors of Salus Scientific Corp., where he advises the company and its board on the legal, regulatory, and corporate issues that come with bringing radiation protection technology to market. His work spans FDA medical device regulation and product classification, quality system and labeling requirements, intellectual property strategy, hospital and distributor contracting, supply chain and vendor agreements, corporate governance, and financing and transactional matters.

Jon brings an operator's perspective to the role. He has served as chief executive officer of, and as a director of, pharmaceutical and related companies, and that experience shapes how he counsels Salus on commercialization, growth, and board-level strategy. A pharmacist as well as a lawyer, Jon has built his career in drug, medical device, and health law — including FDA matters, board licensing and permitting, controlled substances, and federal and state compliance governing the purchase and sale of pharmaceutical and medical device products. He began his legal career at Nelson Mullins Riley & Scarborough LLP.

Jon is an Adjunct Clinical Professor in the Department of Clinical Pharmacy and Outcome Sciences at the Medical University of South Carolina College of Pharmacy, and has served in the same role at the University of South Carolina College of Pharmacy. He earned his B.S. in Pharmacy from the University of North Carolina at Chapel Hill and his J.D., magna cum laude, from the University of South Carolina School of Law, where he was Associate Editor-in-Chief of the South Carolina Law Review.

Read More

Jon Wallace serves as General Counsel and as a member of the Board of Directors of Salus Scientific Corp., where he advises the company and its board on the legal, regulatory, and corporate issues that come with bringing radiation protection technology to market. His work spans FDA medical device regulation and product classification, quality system and labeling requirements, intellectual property strategy, hospital and distributor contracting, supply chain and vendor agreements, corporate governance, and financing and transactional matters.

Jon brings an operator's perspective to the role. He has served as chief executive officer of, and as a director of, pharmaceutical and related companies, and that experience shapes how he counsels Salus on commercialization, growth, and board-level strategy. A pharmacist as well as a lawyer, Jon has built his career in drug, medical device, and health law — including FDA matters, board licensing and permitting, controlled substances, and federal and state compliance governing the purchase and sale of pharmaceutical and medical device products. He began his legal career at Nelson Mullins Riley & Scarborough LLP.

Jon is an Adjunct Clinical Professor in the Department of Clinical Pharmacy and Outcome Sciences at the Medical University of South Carolina College of Pharmacy, and has served in the same role at the University of South Carolina College of Pharmacy. He earned his B.S. in Pharmacy from the University of North Carolina at Chapel Hill and his J.D., magna cum laude, from the University of South Carolina School of Law, where he was Associate Editor-in-Chief of the South Carolina Law Review.

Read More

Mike Lankford

Vice President of Sales

Michael Lankford is Vice President of Sales at Salus Scientific, where he leads U.S. commercial strategy, sales execution and market expansion across interventional specialties. He works closely with the company's clinical, marketing and product teams to accelerate adoption of its radiation protection and occupational wellness portfolio among physicians, hospitals and health systems.

Lankford brings more than two decades of medical device experience, including 16 years in senior sales leadership at high-growth healthcare companies. Before joining Salus, he spent seven years leading the commercial organization at Verge Medical, a private medical technology company focused on aortic-ostial disease. His career includes two successful startup exits.

He holds a B.A. in Communications from North Carolina State University.

Read More

Michael Lankford is Vice President of Sales at Salus Scientific, where he leads U.S. commercial strategy, sales execution and market expansion across interventional specialties. He works closely with the company's clinical, marketing and product teams to accelerate adoption of its radiation protection and occupational wellness portfolio among physicians, hospitals and health systems.

Lankford brings more than two decades of medical device experience, including 16 years in senior sales leadership at high-growth healthcare companies. Before joining Salus, he spent seven years leading the commercial organization at Verge Medical, a private medical technology company focused on aortic-ostial disease. His career includes two successful startup exits.

He holds a B.A. in Communications from North Carolina State University.

Read More

Michael Lankford is Vice President of Sales at Salus Scientific, where he leads U.S. commercial strategy, sales execution and market expansion across interventional specialties. He works closely with the company's clinical, marketing and product teams to accelerate adoption of its radiation protection and occupational wellness portfolio among physicians, hospitals and health systems.

Lankford brings more than two decades of medical device experience, including 16 years in senior sales leadership at high-growth healthcare companies. Before joining Salus, he spent seven years leading the commercial organization at Verge Medical, a private medical technology company focused on aortic-ostial disease. His career includes two successful startup exits.

He holds a B.A. in Communications from North Carolina State University.

Read More

Dan Lormon

Vice President of Global Medical Affairs & Engagement

Dan Lormon is Vice President of Global Medical Affairs and Engagement at Salus Scientific, where he leads clinical strategy, global physician education, medical society relations and clinical marketing. He is focused on advancing the safety, workflow and adoption of the company's radiation protection solutions worldwide.

Lormon brings more than 20 years of medical device experience in cardiovascular markets, with expertise spanning clinical affairs, physician engagement, medical education, strategic events and marketing communications. He holds a bachelor's degree from the University of California, Davis.

Read More

Dan Lormon is Vice President of Global Medical Affairs and Engagement at Salus Scientific, where he leads clinical strategy, global physician education, medical society relations and clinical marketing. He is focused on advancing the safety, workflow and adoption of the company's radiation protection solutions worldwide.

Lormon brings more than 20 years of medical device experience in cardiovascular markets, with expertise spanning clinical affairs, physician engagement, medical education, strategic events and marketing communications. He holds a bachelor's degree from the University of California, Davis.

Read More

Dan Lormon is Vice President of Global Medical Affairs and Engagement at Salus Scientific, where he leads clinical strategy, global physician education, medical society relations and clinical marketing. He is focused on advancing the safety, workflow and adoption of the company's radiation protection solutions worldwide.

Lormon brings more than 20 years of medical device experience in cardiovascular markets, with expertise spanning clinical affairs, physician engagement, medical education, strategic events and marketing communications. He holds a bachelor's degree from the University of California, Davis.

Read More

Nick Tomczak

Vice President of Engineering

Nick Tomczak is Vice President of Engineering at Salus Scientific Corp., where he leads product development and engineering for the company’s radiation protection portfolio, including the GLiFT™ endoskeleton system, the AeroShield™ enhanced radiation protection device, and Salus Garments. He brings more than 15 years of engineering experience include TransEnterix, Multitasker Tools, MagPod, Jewel Engineering, and WarSport Manufacturing to Salus’s mission of engineering safer labs without compromising clinical workflow, with a focus on design validation, material science, and long-term product durability. Nick holds a BS in Mechanical Engineering from Florida International University.

Read More

Nick Tomczak is Vice President of Engineering at Salus Scientific Corp., where he leads product development and engineering for the company’s radiation protection portfolio, including the GLiFT™ endoskeleton system, the AeroShield™ enhanced radiation protection device, and Salus Garments. He brings more than 15 years of engineering experience include TransEnterix, Multitasker Tools, MagPod, Jewel Engineering, and WarSport Manufacturing to Salus’s mission of engineering safer labs without compromising clinical workflow, with a focus on design validation, material science, and long-term product durability. Nick holds a BS in Mechanical Engineering from Florida International University.

Read More

Nick Tomczak is Vice President of Engineering at Salus Scientific Corp., where he leads product development and engineering for the company’s radiation protection portfolio, including the GLiFT™ endoskeleton system, the AeroShield™ enhanced radiation protection device, and Salus Garments. He brings more than 15 years of engineering experience include TransEnterix, Multitasker Tools, MagPod, Jewel Engineering, and WarSport Manufacturing to Salus’s mission of engineering safer labs without compromising clinical workflow, with a focus on design validation, material science, and long-term product durability. Nick holds a BS in Mechanical Engineering from Florida International University.

Read More

Ty Dawson

Vice President of Operations

Ty Dawson is Vice President of Operations at Salus Scientific, bringing more than 20 years of experience in executive leadership, global operations, and product innovation. At Salus, Ty leads manufacturing, quality systems, and field service. He has played a central role in scaling the company’s G-LiFT operations in Charleston and establishing its Spartanburg operations for AeroShield engineering and production.

Prior to joining Salus, Ty served as CEO of Rugged Solutions America, where he led the company’s acquisition strategy, integrated six businesses, and built a scalable operating platform. Earlier, he spent more than 15 years with Milliken, including six years as Vice President with responsibility for business strategy and operations across the U.S., United Kingdom, and China. Ty holds a PhD in Mechanical Engineering from the Georgia Institute of Technology.

Read More

Ty Dawson is Vice President of Operations at Salus Scientific, bringing more than 20 years of experience in executive leadership, global operations, and product innovation. At Salus, Ty leads manufacturing, quality systems, and field service. He has played a central role in scaling the company’s G-LiFT operations in Charleston and establishing its Spartanburg operations for AeroShield engineering and production.

Prior to joining Salus, Ty served as CEO of Rugged Solutions America, where he led the company’s acquisition strategy, integrated six businesses, and built a scalable operating platform. Earlier, he spent more than 15 years with Milliken, including six years as Vice President with responsibility for business strategy and operations across the U.S., United Kingdom, and China. Ty holds a PhD in Mechanical Engineering from the Georgia Institute of Technology.

Read More

Ty Dawson is Vice President of Operations at Salus Scientific, bringing more than 20 years of experience in executive leadership, global operations, and product innovation. At Salus, Ty leads manufacturing, quality systems, and field service. He has played a central role in scaling the company’s G-LiFT operations in Charleston and establishing its Spartanburg operations for AeroShield engineering and production.

Prior to joining Salus, Ty served as CEO of Rugged Solutions America, where he led the company’s acquisition strategy, integrated six businesses, and built a scalable operating platform. Earlier, he spent more than 15 years with Milliken, including six years as Vice President with responsibility for business strategy and operations across the U.S., United Kingdom, and China. Ty holds a PhD in Mechanical Engineering from the Georgia Institute of Technology.

Read More

Milestones

2016

Original LLC Founded and GLiFT Product Development began

2017

GLiFT Patent written and filed with the USPTO

2018

Dr. Buchanan and Partners tested and studied effectiveness

2020

1st Utility Patent awarded for GLiFT system

2021

Salus Scientific Corp. Created to engineer and create complete radiation protection portfolio

2021

GLiFT 1.0 Beta Testing complete

2021

Cath Lab Digest Story on Lance Lewis, MD GLiFT Experience

2022

GLiFT Pro created to scale GLiFT technology all over the world

2023

Salus Scientific Seed Round Completed

2024

Salus stands up its first production facility in Charleston, SC, GLiFT Pro commercialization

2025

Salus Shield and PeRM Programs Launched

2025

First Complete year of GLiFT Commercialization

January 2026

AeroShield Bench Study completed

February 2026

Salus Scientific installs its first AeroShield ERPD system at Tallahassee Memorial Healthcare, Tallahassee, FL

March 2026

AeroShield Real-world Early Experience presented, CRT, Washington, DC

July 2026

Salus stands up second production facility in Spartanburg, SC

August 2026

Series A Financing Round Closed

September 2026

AeroShield Commercialization Begins

2016

Original LLC Founded and GLiFT Product Development began

2017

GLiFT Patent written and filed with the USPTO

2018

Dr. Buchanan and Partners tested and studied effectiveness

2020

1st Utility Patent awarded for GLiFT system

2021

Salus Scientific Corp. Created to engineer and create complete radiation protection portfolio

2021

GLiFT 1.0 Beta Testing complete

2021

Cath Lab Digest Story on Lance Lewis, MD GLiFT Experience

2022

GLiFT Pro created to scale GLiFT technology all over the world

2023

Salus Scientific Seed Round Completed

2024

Salus stands up its first production facility in Charleston, SC, GLiFT Pro commercialization

2025

Salus Shield and PeRM Programs Launched

2025

First Complete year of GLiFT Commercialization

January 2026

AeroShield Bench Study completed

February 2026

Salus Scientific installs its first AeroShield ERPD system at Tallahassee Memorial Healthcare, Tallahassee, FL

March 2026

AeroShield Real-world Early Experience presented, CRT, Washington, DC

July 2026

Salus stands up second production facility in Spartanburg, SC

August 2026

Series A Financing Round Closed

September 2026

AeroShield Commercialization Begins

2016

Original LLC Founded and GLiFT Product Development began

2017

GLiFT Patent written and filed with the USPTO

2018

Dr. Buchanan and Partners tested and studied effectiveness

2020

1st Utility Patent awarded for GLiFT system

2021

Salus Scientific Corp. Created to engineer and create complete radiation protection portfolio

2021

GLiFT 1.0 Beta Testing complete

2021

Cath Lab Digest Story on Lance Lewis, MD GLiFT Experience

2022

GLiFT Pro created to scale GLiFT technology all over the world

2023

Salus Scientific Seed Round Completed

2024

Salus stands up its first production facility in Charleston, SC, GLiFT Pro commercialization

2025

Salus Shield and PeRM Programs Launched

2025

First Complete year of GLiFT Commercialization

January 2026

AeroShield Bench Study completed

February 2026

Salus Scientific installs its first AeroShield ERPD system at Tallahassee Memorial Healthcare, Tallahassee, FL

March 2026

AeroShield Real-world Early Experience presented, CRT, Washington, DC

July 2026

Salus stands up second production facility in Spartanburg, SC

August 2026

Series A Financing Round Closed

September 2026

AeroShield Commercialization Begins